More on BNTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-38.8% Growth)
- Ratings (7.4 Score)

Upcoming Events

- Earnings (11/3/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BioNTech SE (NQ:BNTX)
Delayed: 102.94 -8.46 (7.59%)
Prev. Close $111.40  
Open$102.34 
52 Wk High$ 
52 Wk Low$ 
Day High$105.23 
Day Low$98.80 
P/E N/A  
EPS$ 
Volume2,262,707 

Friends, Peers and Foes (?): 0A3M, PFE, MRNA, NVAX, AZN (more...)

Aug 28, 2026 09:46 AM BioNTech drops 10% on mRNA trial failure, highlighting Moderna contrast
Aug 28, 2026 09:09 AM BioNTech ends colorectal cancer mRNA therapy trial early
Aug 28, 2026 09:06 AM Form 6-K BioNTech SE For: Aug 28
Aug 27, 2026 04:55 PM Form 6-K BioNTech SE For: Aug 27
Aug 27, 2026 04:30 PM FDA approves Pfizer-BioNTech XFG-targeted Covid-19 vaccine
Aug 27, 2026 04:30 PM Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine
Aug 26, 2026 09:20 AM A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
Aug 20, 2026 07:37 AM Form 6-K BioNTech SE For: Aug 20
Aug 20, 2026 07:23 AM These 25 S&P 500 stocks saw the largest increase in institutional ownership in Q2
Aug 5, 2026 08:52 AM BioNTech SE (BNTX) Misses Q2 EPS by 18c
View All Articles

Entities mentioned with BNTX

View All Entities